Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways
The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are natural products, which inhibit heterotrimeric Gα proteins with high potency and outstanding selectivity. Historically, pharmacological modulation of Gα proteins was only achieved by treatment with pertussis toxin and cholera toxin,...
Gespeichert in:
Veröffentlicht in: | ACS pharmacology & translational science 2023-12, Vol.6 (12), p.1790-1800 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1800 |
---|---|
container_issue | 12 |
container_start_page | 1790 |
container_title | ACS pharmacology & translational science |
container_volume | 6 |
creator | Voss, Jan Hendrik |
description | The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are natural products, which inhibit heterotrimeric Gα
proteins with high potency and outstanding selectivity. Historically, pharmacological modulation of Gα proteins was only achieved by treatment with pertussis toxin and cholera toxin, whose application can be tedious and is restricted to the inhibition of Gα
proteins and activation of Gα
proteins, respectively. The breakthrough discovery and characterization of YM and FR rendered the closely related Gα
, Gα
, and Gα
proteins amenable to pharmacological inhibition, and since then, both compounds have become widely used in molecular pharmacology and were also proven to be efficacious in animal models of disease. In the past years, both YM and FR were thoroughly characterized and have substantially contributed to an improved understanding of Gα
signaling on a molecular and cellular level. Yet, the possibilities to interrogate Gα
signaling in complex systems have only been exploited in a very limited number of studies, whose promising initial results warrant further application of YM and FR in basic and translational research. As both compounds have become commercially available as of late, this review focuses on their application in cell-based assays and in vivo systems, highlighting their qualities as tool compounds and providing instructions for their use. |
doi_str_mv | 10.1021/acsptsci.3c00214 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10714435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2902952197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-3369504875fd3473602853142c0f028dd08bd8277af89c214ebf8a3c2118c17e3</originalsourceid><addsrcrecordid>eNpVUU1PJCEQJWY3alzvngzHvbQW0Ah4MWayuiYajR8HT4QBesR0Q9swbvxZ-0f2Ny3G0eipXlW9elWph9AOgT0ClOwbm8eSbdhjFmrerqFNygVvFAH57RPeQNs5P0LlADCiYB1tMAmKSSY20fO1t2kYfHTe4duUejxLw5iW0eVDfDyOfbCmhBRx6vD9RUN5KxVgEx0-uVZVjytcEj6LxU9TWpji8em_v_hpnxDcXHgXasXhm7CIpg9xga9MefhjXvIP9L0zffbbq7iF7k5-3c5-N-eXp2ez4_PGMiVKw9iB4tBKwTvHWsEOgErOSEstdBU6B3LuJBXCdFLZ-gM_76RhFRFpifBsCx296Y7L-eCd9bFMptfjFAYzvehkgv7aieFBL9KzJiBI2zJeFX6uFKb0tPS56CFk6_veRJ-WWVMFVHFKlKhUeKPaKeU8-e5jDwH9apl-t0yvLKsju5_v-xh4N4j9ByJWknM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2902952197</pqid></control><display><type>article</type><title>Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways</title><source>ACS Journals: American Chemical Society Web Editions</source><source>NCBI_PubMed Central(免费)</source><creator>Voss, Jan Hendrik</creator><creatorcontrib>Voss, Jan Hendrik</creatorcontrib><description>The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are natural products, which inhibit heterotrimeric Gα
proteins with high potency and outstanding selectivity. Historically, pharmacological modulation of Gα proteins was only achieved by treatment with pertussis toxin and cholera toxin, whose application can be tedious and is restricted to the inhibition of Gα
proteins and activation of Gα
proteins, respectively. The breakthrough discovery and characterization of YM and FR rendered the closely related Gα
, Gα
, and Gα
proteins amenable to pharmacological inhibition, and since then, both compounds have become widely used in molecular pharmacology and were also proven to be efficacious in animal models of disease. In the past years, both YM and FR were thoroughly characterized and have substantially contributed to an improved understanding of Gα
signaling on a molecular and cellular level. Yet, the possibilities to interrogate Gα
signaling in complex systems have only been exploited in a very limited number of studies, whose promising initial results warrant further application of YM and FR in basic and translational research. As both compounds have become commercially available as of late, this review focuses on their application in cell-based assays and in vivo systems, highlighting their qualities as tool compounds and providing instructions for their use.</description><identifier>ISSN: 2575-9108</identifier><identifier>EISSN: 2575-9108</identifier><identifier>DOI: 10.1021/acsptsci.3c00214</identifier><identifier>PMID: 38093837</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Review</subject><ispartof>ACS pharmacology & translational science, 2023-12, Vol.6 (12), p.1790-1800</ispartof><rights>2023 The Author. Published by American Chemical Society.</rights><rights>2023 The Author. Published by American Chemical Society 2023 The Author</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-3369504875fd3473602853142c0f028dd08bd8277af89c214ebf8a3c2118c17e3</citedby><cites>FETCH-LOGICAL-c397t-3369504875fd3473602853142c0f028dd08bd8277af89c214ebf8a3c2118c17e3</cites><orcidid>0000-0003-0595-4607</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714435/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714435/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,2765,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38093837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Voss, Jan Hendrik</creatorcontrib><title>Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways</title><title>ACS pharmacology & translational science</title><addtitle>ACS Pharmacol Transl Sci</addtitle><description>The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are natural products, which inhibit heterotrimeric Gα
proteins with high potency and outstanding selectivity. Historically, pharmacological modulation of Gα proteins was only achieved by treatment with pertussis toxin and cholera toxin, whose application can be tedious and is restricted to the inhibition of Gα
proteins and activation of Gα
proteins, respectively. The breakthrough discovery and characterization of YM and FR rendered the closely related Gα
, Gα
, and Gα
proteins amenable to pharmacological inhibition, and since then, both compounds have become widely used in molecular pharmacology and were also proven to be efficacious in animal models of disease. In the past years, both YM and FR were thoroughly characterized and have substantially contributed to an improved understanding of Gα
signaling on a molecular and cellular level. Yet, the possibilities to interrogate Gα
signaling in complex systems have only been exploited in a very limited number of studies, whose promising initial results warrant further application of YM and FR in basic and translational research. As both compounds have become commercially available as of late, this review focuses on their application in cell-based assays and in vivo systems, highlighting their qualities as tool compounds and providing instructions for their use.</description><subject>Review</subject><issn>2575-9108</issn><issn>2575-9108</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVUU1PJCEQJWY3alzvngzHvbQW0Ah4MWayuiYajR8HT4QBesR0Q9swbvxZ-0f2Ny3G0eipXlW9elWph9AOgT0ClOwbm8eSbdhjFmrerqFNygVvFAH57RPeQNs5P0LlADCiYB1tMAmKSSY20fO1t2kYfHTe4duUejxLw5iW0eVDfDyOfbCmhBRx6vD9RUN5KxVgEx0-uVZVjytcEj6LxU9TWpji8em_v_hpnxDcXHgXasXhm7CIpg9xga9MefhjXvIP9L0zffbbq7iF7k5-3c5-N-eXp2ez4_PGMiVKw9iB4tBKwTvHWsEOgErOSEstdBU6B3LuJBXCdFLZ-gM_76RhFRFpifBsCx296Y7L-eCd9bFMptfjFAYzvehkgv7aieFBL9KzJiBI2zJeFX6uFKb0tPS56CFk6_veRJ-WWVMFVHFKlKhUeKPaKeU8-e5jDwH9apl-t0yvLKsju5_v-xh4N4j9ByJWknM</recordid><startdate>20231208</startdate><enddate>20231208</enddate><creator>Voss, Jan Hendrik</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0595-4607</orcidid></search><sort><creationdate>20231208</creationdate><title>Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways</title><author>Voss, Jan Hendrik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-3369504875fd3473602853142c0f028dd08bd8277af89c214ebf8a3c2118c17e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Voss, Jan Hendrik</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS pharmacology & translational science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Voss, Jan Hendrik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways</atitle><jtitle>ACS pharmacology & translational science</jtitle><addtitle>ACS Pharmacol Transl Sci</addtitle><date>2023-12-08</date><risdate>2023</risdate><volume>6</volume><issue>12</issue><spage>1790</spage><epage>1800</epage><pages>1790-1800</pages><issn>2575-9108</issn><eissn>2575-9108</eissn><abstract>The macrocyclic depsipeptides YM-254890 (YM) and FR900359 (FR) are natural products, which inhibit heterotrimeric Gα
proteins with high potency and outstanding selectivity. Historically, pharmacological modulation of Gα proteins was only achieved by treatment with pertussis toxin and cholera toxin, whose application can be tedious and is restricted to the inhibition of Gα
proteins and activation of Gα
proteins, respectively. The breakthrough discovery and characterization of YM and FR rendered the closely related Gα
, Gα
, and Gα
proteins amenable to pharmacological inhibition, and since then, both compounds have become widely used in molecular pharmacology and were also proven to be efficacious in animal models of disease. In the past years, both YM and FR were thoroughly characterized and have substantially contributed to an improved understanding of Gα
signaling on a molecular and cellular level. Yet, the possibilities to interrogate Gα
signaling in complex systems have only been exploited in a very limited number of studies, whose promising initial results warrant further application of YM and FR in basic and translational research. As both compounds have become commercially available as of late, this review focuses on their application in cell-based assays and in vivo systems, highlighting their qualities as tool compounds and providing instructions for their use.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>38093837</pmid><doi>10.1021/acsptsci.3c00214</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-0595-4607</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2575-9108 |
ispartof | ACS pharmacology & translational science, 2023-12, Vol.6 (12), p.1790-1800 |
issn | 2575-9108 2575-9108 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10714435 |
source | ACS Journals: American Chemical Society Web Editions; NCBI_PubMed Central(免费) |
subjects | Review |
title | Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα q/11 -Mediated Signaling Pathways |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A22%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recommended%20Tool%20Compounds:%20Application%20of%20YM-254890%20and%20FR900359%20to%20Interrogate%20G%CE%B1%20q/11%20-Mediated%20Signaling%20Pathways&rft.jtitle=ACS%20pharmacology%20&%20translational%20science&rft.au=Voss,%20Jan%20Hendrik&rft.date=2023-12-08&rft.volume=6&rft.issue=12&rft.spage=1790&rft.epage=1800&rft.pages=1790-1800&rft.issn=2575-9108&rft.eissn=2575-9108&rft_id=info:doi/10.1021/acsptsci.3c00214&rft_dat=%3Cproquest_pubme%3E2902952197%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2902952197&rft_id=info:pmid/38093837&rfr_iscdi=true |